A retrospective review of the persistence of bDMARDs prescribed for the treatment of rheumatoid arthritis in the Australian population

This study aimed to describe the persistence of biologic disease modifying anti-rheumatic drugs (bDMARDs) in Australian rheumatoid arthritis (RA) patients.

Authors: Graeme Jones, Stephen Hall, Paul Bird, Geoff Littlejohn, Kathleen Tymms, Peter Youssef, Eric Chung, Rina Barrett, Peter Button

International Journal of Rheumatic Diseases 2018; 21: 1581–1590

Download document